Sponsor pipeline

SOFIE clinical trial pipeline

Get alerts when SOFIE's trials change

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.

Notable

18F-FAPI-74 GI · [18F]FAPI-74 PET · Gastrointestinal Cancers

Results posted: Oct 1, 2026

SOFIEPhase 2 NCT05641896 Registry history of NCT05641896 on ClinicalTrials.gov (opens the registry)

Oct 1, 2026

Show 2 trials with minor changes only

Minor

FAPI-PRO · Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

Trial sites expanded: 16 → 19 locations

SOFIEPhase 3 NCT07217717 Registry history of NCT07217717 on ClinicalTrials.gov (opens the registry)

Oct 19, 2026
Minor

FAPI-GO · Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer

Trial sites expanded: 16 → 19 locations

SOFIEPhase 3 NCT07217704 Registry history of NCT07217704 on ClinicalTrials.gov (opens the registry)

Oct 19, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 3

2

Disease areas by active trials

Esophageal Cancer (1) · Gastric Cancer (1) · Pancreatic Cancer (1)

Get alerts when SOFIE's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.

Start monitoring free